Medroxyprogesterone Acetate News and Research

RSS
Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

Women using DMPA experience high BMD loss, researchers say

Women using DMPA experience high BMD loss, researchers say

Hormone therapy: An important treatment option for post-menopausal women

Hormone therapy: An important treatment option for post-menopausal women

Breast tenderness indicates increased cancer risk among women on combination therapy

Breast tenderness indicates increased cancer risk among women on combination therapy

Researchers identify women at risk of gaining excessive weight with Depo-Provera

Researchers identify women at risk of gaining excessive weight with Depo-Provera

Birth control shot causes significant weight gain

Birth control shot causes significant weight gain

New cream for vaginal dryness approved

New cream for vaginal dryness approved

Synthetic progestin linked to breast cancer

Synthetic progestin linked to breast cancer

Long-term effects of synthetic progestins cause for concern

Long-term effects of synthetic progestins cause for concern

Risks of long-term hormone therapy continue to outweigh benefits

Risks of long-term hormone therapy continue to outweigh benefits

Hormone therapy increases frequency of abnormal mammograms, breast biopsies

Hormone therapy increases frequency of abnormal mammograms, breast biopsies

Wyeth wins HRT trial

Wyeth wins HRT trial

International Menopause Society reaction to report on breast cancer

International Menopause Society reaction to report on breast cancer

No apparent increase in coronary heart disease for women who initiate hormone therapy

No apparent increase in coronary heart disease for women who initiate hormone therapy

Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease

Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

NIH Panel supports use of hormone therapy for treatment of menopausal symptoms

NIH Panel supports use of hormone therapy for treatment of menopausal symptoms

Increased risk of urinary incontinence with hormone therapy

Increased risk of urinary incontinence with hormone therapy

Progestin in hormone therapy could dramatically affect heart attack severity

Progestin in hormone therapy could dramatically affect heart attack severity

Women who take the hormone therapy estrogen plus progestin have double the risk for venous thrombosis

Women who take the hormone therapy estrogen plus progestin have double the risk for venous thrombosis